Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

3(75%)

Results Posted

100%(1 trials)

Phase Distribution

Ph not_applicable

75%

Ph phase_3

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 3Large-scale testing

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(1)

Detailed Status

Recruiting3

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (25.0%)

N/A3 (75.0%)

Trials by Status

recruiting375%

completed125%

Recent Activity

3 active trials

Showing 4 of 4

recruitingnot_applicable

Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure

NCT05710315

recruitingnot_applicable

A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

NCT03530852

recruitingphase_3

Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

NCT06691893

completednot_applicable

Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)

NCT02598128

Clinical Trials (4)

Showing 4 of 4 trials

NCT05710315Not Applicable

Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure

Recruiting

NCT03530852Not Applicable

A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

Recruiting

NCT06691893Phase 3

Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients

Recruiting

NCT02598128Not Applicable

Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)

Completed

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4